Skip to main content
  • About Us
  • Investors
  • Careers
  • Contact us
Choose your market:
United Kingdom
  • Global / English
  • Albania / Gjuha shqipe
  • Algeria / Français
  • Argentina / Español
  • Australia / English
  • Austria / Deutsch
  • Bahrain / English
  • Belgium / English
  • Bolivia / Español
  • Bosnia-Herzegovina / BS
  • Bosnia-Herzegovina / EN
  • Brazil / Português
  • Bulgaria / Български
  • Canada / English
  • Canada / Français
  • Chile / Español
  • China / 简体中文
  • China / English
  • Colombia / Español
  • Costa Rica / Español
  • Croatia / Hrvatski jezik
  • Croatia / English
  • Cyprus / English
  • Czech Republic / český
  • Denmark / Dansk
  • Denmark / English
  • Dominican Republic / ES
  • Ecuador / Español
  • Egypt / English
  • El Salvador / Español
  • France / Français
  • Germany / Deutsch
  • Ghana / English
  • Guatemala / Español
  • Hong Kong SAR China / English
  • Hungary / Magyar nyelv
  • India / English
  • Indonesia / English
  • Iraq / English
  • Ireland / English
  • Israel / Hebrew
  • Italy / Italiano
  • Japan / 日本語
  • Jordan / English
  • Kazakhstan / Pусский
  • Kenya / English
  • Kosovo / Gjuha shqipe
  • Kosovo / Srpski
  • Kuwait / English
  • Lebanon / English
  • Macedonia / Македонски јазик
  • Macedonia / Gjuha shqipe
  • Malaysia / English
  • México / Español
  • Montenegro / Montenegrin
  • Morocco / Français
  • Mozambique / Portuguese
  • Netherlands / Nederlands
  • Netherlands / English
  • New Zealand / English
  • Nigeria / English
  • Norway / Norsk
  • Pakistan / English
  • Panama / Español
  • Peru / Español
  • Philippines / English
  • Poland / Polski
  • Portugal / Português
  • Puerto Rico / English
  • Qatar / English
  • Romania / Română
  • Romania / English
  • Russia / Pусский
  • Saudi Arabia / English
  • Serbia / Srpski
  • Singapore / English
  • Slovakia / Slovenský
  • Slovenia / Slovenščina
  • Slovenia / English
  • South Africa / English
  • South Korea / 한국어
  • Spain / Español
  • Sweden / Svenska
  • Switzerland / English
  • Switzerland / Deutsch
  • Taiwan / English
  • Tanzania / English
  • Thailand / English
  • Tunisia / Français
  • Türkiye / Türkçe
  • UAE / English
  • Uganda / English
  • Ukraine / Українська мова
  • Ukraine / English
  • United Kingdom / English
  • United States / English
  • Venezuela / Español
  • Vietnam / English
  • Zambia / English
  • News & Events
    • All
    • News & Polls
    • Events
    • Webinars
    • Newsletter
  • Innovation & Knowledge
    • All
    • Media & Brand Communication
    • Consumer & Shopper
    • Customer Experience
    • Society
    • New Services
  • Our Solutions
    • All
  • Ipsos.digital platform
  • ESG
  • About us
  • Investors
  • Careers
  • Contact us
  • Ipsos
  • Search

Search

Sort by Date Relevance
We found 34 results matching with your query. Refine by
  • Corporate

    Ipsos Research Highlights - October 2018

    Welcome to our review of October. This month saw a further fall in confidence in Theresa May, more concern about Brexit (only 29% think we'll get a deal), and support for more public spending and tax cuts in the Budget.

    30 October 2018
  • Corporate

    The Reputation Council Report - 2017

    Our twelfth sitting explores how 127 communications leaders across 22 countries are responding to an increasingly fractured communications landscape.

    This year's report examines issues ranging from the impact of Brexit, and tweets from @realDonaldTrump, to the rise of corporate activism, and the implications of Amazon’s Alexa giving Jeff Bezos a microphone into millions of living rooms.

    13 December 2017
  • Corporate

    Patient-Centricity: Decoding The Buzzword

    No matter how you slice it, pharmaceutical companies across the industry are scrambling to be perceived as putting the patient first. But who is making good on this? What more needs to be done?

    20 September 2017
  • Corporate

    Conquering Complexity: The Coming Revolution in Oncology Biomarker Testing

    When it comes to the fight against cancer, we are on the cusp of a revolution. In this article, Pieter De Richter – Ipsos Healthcare’s Head of Oncology Molecular Diagnostics – explores how cancer treatment will change in the coming decades.

    5 June 2017
Pagination
  • First page 1
  • Previous page <
  • Current page 4

Refine by

REFINE YOUR SEARCH FOR KEY WORD

  • (-) Innovation & Knowledge
    • Consumer & Shopper
    • (-) Corporate
    • Customer Experience
    • Media & Brand Communication
    • New Services
    • Society
  • Citizens
  • Consumers & Brands
  • Customers & Employees
  • Doctors & Patients
  • Capabilities
  • About Us
  • Contact Us
  • Press
  • Investors
  • Careers
  • Face to Face Interviewer
© 2016 - 2025 Ipsos All Rights Reserved
  • Legal
  • Privacy & Data Protection
  • Cookie Policy
  • Tax Strategy
  • Modern Slavery Statement
  • Our Alert System